YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY – Get Free Report) shot up 1.3% during trading on Thursday . The stock traded as high as $16.15 and last traded at $16.07. 129,295 shares traded hands during trading, a decline of 39% from the average session volume of 212,895 shares. The stock had previously closed at $15.86.
YieldMax MRNA Option Income Strategy ETF Trading Down 5.5%
The company has a fifty day moving average price of $16.95 and a 200 day moving average price of $17.37.
About YieldMax MRNA Option Income Strategy ETF
The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.
See Also
- Five stocks we like better than YieldMax MRNA Option Income Strategy ETF
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for YieldMax MRNA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YieldMax MRNA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.
